Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT) Meeting Abstract


Authors: Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Abstract Title: Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
Meeting Title: 41st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 94
Issue: 10 Suppl. 1 Pt. 1
Meeting Dates: 1999 Dec 3-7
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1999-11-15
Start Page: 174a
Language: English
ACCESSION: WOS:000083790300809
PROVIDER: wos
PUBMED: 10590715
Notes: Meeting Abstract: 760 -- Source: Wos
MSK Authors
  1. Joachim Yahalom
    394 Yahalom
  2. Craig Moskowitz
    368 Moskowitz
  3. Jaya M Satagopan
    137 Satagopan
  4. Eric E Hedrick
    16 Hedrick
  5. Andrew D Zelenetz
    546 Zelenetz
  6. Stephen D Nimer
    339 Nimer
  7. Janine   Walits
    2 Walits
Related MSK Work